SCHEMBL641314

SCHEMBL641314

NC(=O)C12CC1CCN2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1026396 1.00 — —
SCHEMBL7392128 0.88 KDM4E (0.34) —
SCHEMBL19243521 0.80 — —
SCHEMBL7315743 0.80 — —
Hydrochloric Acid SCHEMBL14343833 0.78 HSD11B1 (0.32) —
SCHEMBL4874568 0.74 NPSR1 (0.33) —
SCHEMBL16058143 0.68 SLC6A1 (0.32) —
Hydrochloric Acid SCHEMBL23495000 0.67 SLC6A1 (0.31) —
Hydrochloric Acid SCHEMBL23495001 0.67 SLC6A1 (0.31) —
SCHEMBL30601928 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3353155-A1 PYRIDYL OR PYRAZINYL COMPOUNDS CARRYING A METHYL-BOUND ALPHA-AMINO ACID AMIDE GROUP AbbVie Deutschland GmbH & Co. KG (DE) 2018-08-01 — — EP claimed
WO-2017050807-A1 PYRIDYL OR PYRAZINYL COMPOUNDS CARRYING A METHYL-BOUND ALPHA-AMINO ACID AMIDE GROUP AbbVie Deutschland GmbH & Co. KG (DE) 2017-03-30 — — WO claimed
US-20240158372-A1 BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF AMGEN INC. 2024-05-16 — — US disclosed
US-11780826-B2 Bisamide sarcomere activating compounds and uses thereof AMGEN INC. (US) 2023-10-10 — — US disclosed
US-20220281850-A1 BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF AMGEN INC. 2022-09-08 — — US disclosed
US-11254658-B2 Bisamide sarcomere activating compounds and uses thereof AMGEN INC. (US) 2022-02-22 — — US disclosed
US-8895602-B1 6-pyrazolylamido-3-substituted azabicyclo[3.1.0]hexane compounds as calcium channel inhibitors KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-11-25 — — US disclosed
US-20140343295-A1 NOVEL 6-PYRAZOLYLAMIDO-3-SUBSTITUTED AZABICYCLO[3.1.0]HEXANE COMPOUNDS AS CALCIUM CHANNEL INHIBITORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-11-20 — — US disclosed
US-8119673-B2 Compounds 148 ASTRAZENECA AB (SE) 2012-02-21 — — US disclosed
US-20110130432-A1 Heterocyclic Carboxamides For Use As Thrombin Inhibitors ASTRAZENECA AB (SE) 2011-06-02 — — US disclosed
US-20090318517-A1 Novel Compounds 148 ASTRAZENECA AB (SE) 2009-12-24 — — US disclosed
US-20090012087-A1 New Aza-Bicyclohexane Compounds Useful As Inhibitors Of Thrombin ASTRAZENECA AB (SE) 2009-01-08 — — US disclosed
Send feedback